You are using an outdated browser. Please upgrade your browser to improve your experience.

You are using an outdated browser.

To ensure optimal security, this website will soon be unavailable on this browser. Please upgrade your browser to allow continued use of ACP websites.

Hepatitis C: HCV RNA Testing at No Greater Than Week 12 of Treatment

Percentage of patients aged 18 years and older with a diagnosis of chronic hepatitis C who are receiving antiviral treatment for whom quantitative HCV RNA testing was performed at no greater than 12 weeks from initiation of antiviral treatment

Date Reviewed: July 26, 2014

Measure Info

NQF 0398CMS 87NQF Endorsement Removed
Measure Type: 
Process
Measure Steward: 
American Gastroenterological Association
Clinical Topic Area: 
Hepatitis C

Care Setting: 
Outpatient
Data Source: 
Electronic Health Data
Electronic Health Records
Registry

ACP does not support NQF 0398: “Hepatitis C: HCV RNA Testing at No Greater Than Week 12 of Treatment.” Although it is important to measure viral load to assess the efficacy of treatment, clinical guidelines for the treatment of Hepatitis C are evolving and the changes in treatment regimens may alter the appropriate interval and/or frequency of testing.

As part of an ongoing effort to improve user experience, we have made some updates to the Performance Measures section of ACP. Tell us what you think!